Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Gross Margin: 45.1% for Q4; 42.6% for fiscal 2024, up from 36.6% in fiscal 2023. Cash Balance: $276.4 million as of September 30, 2024. SynBio Revenue: $33.9 million for Q4, a 28% increase year-over-year; $123.5 million for fiscal 2024, a 26% increase over fiscal 2023. NGS Revenue: $45.5 million for Q4, a 23% increase year-over-year; $169.1 million for fiscal 2024, a 37% increase over fiscal 2023. Biopharma Revenue: $5.3 million for Q4; $20.3 million for fiscal 2024. Adjusted EBITDA: Loss of approximately $17 million for Q4; loss of approximately $93.5 million for fiscal 2024, an improvement of $54 million over fiscal 2023. Operating Expenses: $74.3 million for Q4; $354 million for fiscal 2024, including a $45 million impairment charge. Capital Expenditures: $5 million for fiscal 2024, a reduction from $28 million in fiscal 2023. Orders: $88.2 million for Q4, a 24% increase year-over-year; $344.2 million for fiscal 2024. Warning! GuruFocus has detected 3 Warning Sig
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- DNA Synthesizer Market Projected to Reach USD 922.11 Million by 2032, Growing at a 14.62% CAGR – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Barclays PLC from $55.00 to $52.00. They now have an "overweight" rating on the stock.MarketBeat
- Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Scotiabank from $50.00 to $54.00. They now have a "sector outperform" rating on the stock.MarketBeat
- Twist Bioscience Co. (NASDAQ: TWST) had its price target raised by analysts at Robert W. Baird from $46.00 to $48.00. They now have an "outperform" rating on the stock.MarketBeat
TWST
Earnings
- 11/18/24 - Beat
TWST
Sec Filings
- 11/18/24 - Form S-8
- 11/18/24 - Form 10-K
- 11/18/24 - Form 8-K
- TWST's page on the SEC website